Latent Tuberculosis Infection Resources
ShareCompartir
Targeted Testing and Treatment Recommendations
CDC Resources for USPSTF Recommendations
- American Journal of Nursing: Tuberculosis: A New Screening Recommendation and an Expanded Approach to Elimination in the United States
- Video: 5 Things to Know About TB
- CDC Messages and Resources [PDF – 592 KB]
- USPSTF LTBI Recommendation: Statement from Dr. Phillip LoBue, Director, CDC’s Division of Tuberculosis Elimination
- Sample Communication Templates for Partners
- USPSTF Recommendation Statement: Screening for Latent Tuberculosis Infection (LTBI) in Adults (slide set)
- Huffington Post: The End Game – Eliminating Tuberculosis In America by NCHHSTP Director Dr. Jonathan Mermin
- CDC Medscape Commentary: New Recommendations to Support Latent Tuberculosis Testing
- The Lancet Infectious Diseases: Latent TB infection: the final frontier of TB elimination in the USA
Social Media Graphics Button and Infographics
![Download: JPG [600x600px]](/tb/publications/ltbi/images/Latent-TB-Infection-Facebook-600x600.jpg){kind=link}
![Download: JPG [500x250px]](/tb/publications/ltbi/images/Latent-TB-Infection-Twitter-v2-500x250.jpg){kind=link}
![Download: JPG [500x250px]](/tb/publications/ltbi/images/Latent-TB-Infection-Twitter-v1-500x250.jpg){kind=link}
Copy the code below to embed this image.(200×200)
Infographics
Fact Sheets
Providers
- The 12-Dose Regimen for Latent TB Infection Treatment: Fact Sheet for Clinicians
- Treatment of Latent TB Infection: Maximizing Adherence
- Treatment Options of Latent Tuberculosis Infection
- Targeted Tuberculosis Testing and Interpreting Tuberculin Skin Test Results
- Frequently Asked Questions on the 12-dose regimen for Latent TB Infection for Providers
- Frequently Asked Questions on the 12-dose regimen for Latent TB Infection for Pharmacists
Patients
- Testing for Tuberculosis
- 12-Dose Regimen for Latent TB Infection
- Isoniazid-specific regimen
- Rifampin-specific regimen
- What You Need to Know About Your Medicine for Latent Tuberculosis (TB) Infection – Isoniazid and Rifapentine
- 12-Dose Regimen for Latent TB Infection-Medication Tracker and Symptom Checklist
CDC Guidance
- Update on Recommendations for Use of Once-weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium Tuberculosis Infection
- Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
Additional Resources
- USPSTF Latent Tuberculosis Infection: Screening Recommendation
- The Journal of the American Medical Association (JAMA)
- Bright Futures Recommendations for Pediatric Preventive Health Care
- Latent TB Infection in the United States – Published Estimates
CDC Resources for USPSTF Recommendations
- American Journal of Nursing: Tuberculosis: A New Screening Recommendation and an Expanded Approach to Elimination in the United States
- Video: 5 Things to Know About TB
- CDC Messages and Resources [PDF – 592 KB]
- USPSTF LTBI Recommendation: Statement from Dr. Phillip LoBue, Director, CDC’s Division of Tuberculosis Elimination
- Sample Communication Templates for Partners
- USPSTF Recommendation Statement: Screening for Latent Tuberculosis Infection (LTBI) in Adults (slide set)
- Huffington Post: The End Game – Eliminating Tuberculosis In America by NCHHSTP Director Dr. Jonathan Mermin
- CDC Medscape Commentary: New Recommendations to Support Latent Tuberculosis Testing
- The Lancet Infectious Diseases: Latent TB infection: the final frontier of TB elimination in the USA
Social Media Graphics, Web Button, and Infographics
Copy the code below to embed this image.(200×200)
Infographics
Fact Sheets
Providers
- The 12-Dose Regimen for Latent TB Infection Treatment: Fact Sheet for Clinicians
- Treatment of Latent TB Infection: Maximizing Adherence
- Treatment Options of Latent Tuberculosis Infection
- Targeted Tuberculosis Testing and Interpreting Tuberculin Skin Test Results
- Frequently Asked Questions on the 12-dose regimen for Latent TB Infection for Providers
- Frequently Asked Questions on the 12-dose regimen for Latent TB Infection for Pharmacists
Patients
- Testing for Tuberculosis
- 12-Dose Regimen for Latent TB Infection
- Isoniazid-specific regimen
- Rifampin-specific regimen
- What You Need to Know About Your Medicine for Latent Tuberculosis (TB) Infection – Isoniazid and Rifapentine
- 12-Dose Regimen for Latent TB Infection-Medication Tracker and Symptom Checklist
- Page last reviewed: May 11, 2017
- Page last updated: June 29, 2018
- Content source: